Click here for slides on this topic


Alpha-glucosidase

An enzyme that catalyzes the release of glucose from certain types of carbohydrates known as glucosides.
The following content matched the glossary term: Alpha-glucosidase

Treating type 2 diabetes: how safe are current therapeutic agents?

Top

Philippe J, Raccah D. Treating type 2 diabetes: how safe are current therapeutic agents?. Int J Clin Pract. 2009;63(2):321-332. Sulphonylureas (SUs) and biguanides (metformin) are the current mainstays in the treatment of type 2 diabetes (T2DM) and represent the most commonly used oral hypoglycaemic agents (OHAs).

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance R2

Top

Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova-Kurktschiev T. Acarbose Slows Progression of Intima-Media Thickness of the Carotid Arteries in Subjects with Impaired Glucose Tolerance R2. Stroke. 2004;35:1073-1078. Impaired glucose tolerance (IGT)-a prediabetic state-is an important risk factor for atherosclerosis.

Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients with Impaired Glucose Tolerance: The STOP-NIDDM Trial

Top

Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients with Impaired Glucose Tolerance: The STOP-NIDDM Trial. JAMA. 2003;290:486-494. OBJECTIVE: To evaluate the effect of decreasing postprandial hyperglycemia with acarbose, an alpha-glucosidase inhibitor, on the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance (IGT).



Slide Library Results

Search Results for: Alpha-glucosidase Slides Found: 4
ADA Nutrition Guidelines: Priorities for Nutrition Management By Medication
IDF 2012 Type 2 Diabetes Guidelines Glucose Treatment Management | NDEI
Reports of Acute Pancreatitis Type 2 Diabetes Drugs | NDEI
Metabolic Surgery Postoperative Follow-Up for Type 2 Diabetes Guidelines | NDEI